The Healthcare Distribution Alliance (HDA) has honored Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc., with the 2018 Distribution Management Award (DMA) for Industry Leadership. The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.
HDA President and CEO John M. Gray released the following statement in response to Attorney General Jeff Sessions' recent memo regarding opioid production quotas.
Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.
In a letter to the Drug Enforcement Administration (DEA) Acting Administrator Robert Patterson, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray called for a “universal” database to support enhanced monitoring of suspicious orders of controlled substances, including controlled opioid drugs. While the DEA has indicated that it currently is developing a suspicious orders database for its own use, HDA’s latest letter calls for the agency to share this data, and DEA’s advanced analytical tools, with state regulators and state/local law enforcement officials to improve information sharing and coordination.
Following the Drug Enforcement Administration’s (DEA) announcement yesterday regarding a new assessment tool for controlled substance orders, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
